Neuromyelitis optica spectrum disorders
about a case
DOI:
https://doi.org/10.70313/2718.7446.v17.n03.355Keywords:
optic neuromyelitis, demyelinating disease, neuroophthalmologyAbstract
In the present work, a clinical case related to neuromyelitis optica spectrum disorders will be developed. The suspicion begins with the peculiar and atypical presentation in a young female patient whose only symptoms are blurred vision and decreased visual acuity after physical exertion. The remaining ophthalmological examination was within the parameters considered normal, so complementary studies were requested, showing, in the magnetic resonance imaging, lesions compatible with demyelinating disease and bilateral campimetric alterations. Given these findings, the corresponding treatment was initiated, with pulses of intravenous corticosteroids. Given the failure of the first line of treatment, plasmapheresis was immediately indicated, with which a prompt improvement was obtained in visual acuity. We emphasize the importance of early diagnosis to prevent relapses with serious sequelae.
References
Huda S, Whittam D, Bhojak M et al. Neuromyelitis optica spectrum disorders. Clin Med (Lond) 2019; 19: 169-176.
Jarius S, Paul F, Weinshenker BG et al. Neuromyelitis optica. Nat Rev Dis Primers 2020; 6: 85.
Wingerchuk DM, Lennon VA, Lucchinetti CF et al. The spectrum of neuromyelitis optica. Lancet Neurol 2007; 6: 805-815.
Shumway CL, Patel BC, Tripathy K, De Jesus O. Neuromyelitis optica spectrum disorder (NMOSD). En: StatPearls [en línea]. Treasure Island (FL): StatPearls Publishing, 2024 Jan 8. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34283474/
Gracia F, Ramírez D, Parajeles-Vindas A et al. Neuromyelitis optica spectrum disorder in Central America and the Caribbean: a multinational clinical characterization study. Neurol Int 2022; 14: 284-293.
Rojas JI, González SJ, Patrucco L, Cristiano E. Neuromielitis óptica: actualización de los conceptos clínicos y fisiopatológicos de la enfermedad. Rev Hosp Ital B Aires 2011; 31: 14-20. Disponible en: https://www1.hospitalitaliano.org.ar/multimedia/archivos/noticias_attachs/47/documentos/9191_14-20-Revision-Rojas-31-1.pdf
Lopategui Cabezas I, Cervantes Llano M, Pentón Rol G. Neuromielitis óptica: principales diferencias con la esclerosis múltiple. An Med Interna 2008; 25: 294-296.
Meza Poblete C, Canales Fernández. Bases fisiopatológicas del espectro de neuromielitis óptica: ¿qué sabemos? Rev Chil Neuro Psiquiatr 2020; 58: 161-170.
Naphattalung Y, Chuenkongkaew WL, Chirapapaisan N et al. Plasma exchange for acute optic neuritis in neuromyelitis optica or neuromyelitis optica spectrum disorder: a systematic review. Ann Med 2023; 55: 2227422.
Jarius S, Aktas O, Neuromyelitis Optica Study Group (NEMOS) et al. Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis. J Neurol 2023; 270: 3341-3368.
Levy M. Plasmapheresis for acute attacks in neuromyelitis optica spectrum disorders. Neurol Neuroimmunol Neuroinflamm 2018; 5: e510.
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Consejo Argentino de Oftalmología
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Con esta licencia no se permite un uso comercial de la obra original, ni la generación de obras derivadas. Las licencias Creative Commons permiten a los autores compartir y liberar sus obras en forma legal y segura.
